| Year |
Citation |
Score |
| 2022 |
Shefner JM, Bedlack R, Andrews JA, Berry JD, Bowser R, Brown R, Glass JD, Maragakis NJ, Miller TM, Rothstein JD, Cudkowicz ME. Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review. Jama Neurology. PMID 36251310 DOI: 10.1001/jamaneurol.2022.3282 |
0.421 |
|
| 2022 |
Maragakis NJ, Rothstein JD. The Evolving Landscape of Motor Neuron Disease Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 36171516 DOI: 10.1007/s13311-022-01307-7 |
0.51 |
|
| 2022 |
Johns AE, Maragakis NJ. Exploring Motor Neuron Diseases Using iPSC Platforms. Stem Cells (Dayton, Ohio). 40: 2-13. PMID 35511862 DOI: 10.1093/stmcls/sxab006 |
0.336 |
|
| 2022 |
Almad AA, Taga A, Joseph J, Gross SK, Welsh C, Patankar A, Richard JP, Rust K, Pokharel A, Plott C, Lillo M, Dastgheyb R, Eggan K, Haughey N, Contreras JE, ... Maragakis NJ, et al. Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. Proceedings of the National Academy of Sciences of the United States of America. 119: e2107391119. PMID 35312356 DOI: 10.1073/pnas.2107391119 |
0.304 |
|
| 2022 |
Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, Ramamoorthy D, Lima L, Vaibhav V, Matlock A, Frank A, Coyne AN, Landin B, Ornelas L, Mosmiller E, ... ... Maragakis N, et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nature Neuroscience. 25: 226-237. PMID 35115730 DOI: 10.1038/s41593-021-01006-0 |
0.493 |
|
| 2022 |
Li Q, Feng Y, Xue Y, Zhan X, Fu Y, Gui G, Zhou W, Richard JP, Taga A, Li P, Mao X, Maragakis NJ, Ying M. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Molecular Neurodegeneration. 17: 8. PMID 35012575 DOI: 10.1186/s13024-021-00510-y |
0.344 |
|
| 2021 |
Lee H, Lee JJ, Park NY, Dubey SK, Kim T, Ruan K, Lim SB, Park SH, Ha S, Kovlyagina I, Kim KT, Kim S, Oh Y, Kim H, Kang SU, ... ... Maragakis NJ, et al. Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nature Neuroscience. PMID 34782793 DOI: 10.1038/s41593-021-00944-z |
0.332 |
|
| 2021 |
Taga A, Habela CW, Johns A, Liu S, O'Brien M, Maragakis NJ. Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons. Journal of Visualized Experiments : Jove. PMID 34515684 DOI: 10.3791/62726 |
0.301 |
|
| 2021 |
Johnson JO, Chia R, Miller DE, Li R, Kumaran R, Abramzon Y, Alahmady N, Renton AE, Topp SD, Gibbs JR, Cookson MR, Sabir MS, Dalgard CL, Troakes C, Jones AR, ... ... Maragakis NJ, et al. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 34459874 DOI: 10.1001/jamaneurol.2021.2598 |
0.457 |
|
| 2020 |
Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, Glass J, Maragakis NJ, Miller TM, Paganoni S, Rothstein JD, Shefner JM, Simmons Z, Weiss MD, Bedlack RS. Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities. Muscle & Nerve. PMID 32445195 DOI: 10.1002/Mus.26989 |
0.434 |
|
| 2019 |
Agurto C, Ahmad O, Cecchi GA, Norel R, Pietrowicz M, Eyigoz EK, Mosmiller E, Baxi E, Rothstein JD, Roy P, Berry J, Maragakis NJ. Analyzing progression of motor and speech impairment in ALS. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2019: 6097-6102. PMID 31947236 DOI: 10.1109/EMBC.2019.8857300 |
0.498 |
|
| 2018 |
Hoye ML, Regan MR, Jensen LA, Lake AM, Reddy LV, Vidensky S, Richard JP, Maragakis NJ, Rothstein JD, Dougherty JD, Miller TM. Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis. Brain : a Journal of Neurology. PMID 30007309 DOI: 10.1093/Brain/Awy182 |
0.464 |
|
| 2018 |
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, ... ... Maragakis NJ, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 97: 1268-1283.e6. PMID 29566793 DOI: 10.1016/J.Neuron.2018.02.027 |
0.47 |
|
| 2017 |
Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming GL, Chen H, Zhang SC. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports. PMID 28366455 DOI: 10.1016/J.Stemcr.2017.03.003 |
0.324 |
|
| 2017 |
Peschansky V, Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, ... ... Maragakis N, et al. ALSUntangled 38: L-serine Amyotrophic Lateral Sclerosis. 18: 148-151. PMID 27894192 DOI: 10.1080/21678421.2016.1250353 |
0.41 |
|
| 2017 |
Bedlack R, Fixsen E, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, ... ... Maragakis N, et al. ALSUntangled No. 36: Accilion Amyotrophic Lateral Sclerosis. 18: 142-147. PMID 27685025 DOI: 10.1080/21678421.2016.1215400 |
0.474 |
|
| 2016 |
Choi IY, Lim H, Estrellas K, Mula J, Cohen TV, Zhang Y, Donnelly CJ, Richard JP, Kim YJ, Kim H, Kazuki Y, Oshimura M, Li HL, Hotta A, Rothstein J, ... Maragakis N, et al. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model. Cell Reports. PMID 27239027 DOI: 10.1016/J.Celrep.2016.05.016 |
0.43 |
|
| 2016 |
Fixsen E, Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, ... ... Maragakis N, et al. ALSUntangled No. 35: Hyperbaric Oxygen Therapy* Amyotrophic Lateral Sclerosis. 17: 622-624. PMID 27089115 DOI: 10.3109/21678421.2016.1172818 |
0.417 |
|
| 2016 |
Almad AA, Doreswamy A, Gross SK, Richard JP, Huo Y, Haughey N, Maragakis NJ. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. PMID 27083773 DOI: 10.1002/glia.22989 |
0.361 |
|
| 2016 |
Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, ... ... Maragakis N, et al. ALSUntangled No. 34: GM604 Amyotrophic Lateral Sclerosis. 17: 617-621. PMID 27043278 DOI: 10.3109/21678421.2016.1164940 |
0.418 |
|
| 2015 |
Zhang PW, Haidet-Phillips AM, Pham JT, Lee Y, Huo Y, Tienari PJ, Maragakis NJ, Sattler R, Rothstein JD. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology. Glia. PMID 26295203 DOI: 10.1002/Glia.22903 |
0.478 |
|
| 2015 |
Haidet-Phillips AM, Maragakis NJ. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS). Brain Research. PMID 26187754 DOI: 10.1016/j.brainres.2015.06.035 |
0.306 |
|
| 2015 |
Li Y, Balasubramanian U, Cohen D, Zhang PW, Mosmiller E, Sattler R, Maragakis NJ, Rothstein JD. A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells. Plos One. 10: e0118266. PMID 25760436 DOI: 10.1371/Journal.Pone.0118266 |
0.512 |
|
| 2015 |
Haidet-Phillips AM, Doreswamy A, Gross SK, Tang X, Campanelli JT, Maragakis NJ. Human glial progenitor engraftment and gene expression is independent of the ALS environment. Experimental Neurology. 264: 188-99. PMID 25523812 DOI: 10.1016/j.expneurol.2014.12.011 |
0.313 |
|
| 2015 |
Richard JP, Maragakis NJ. Induced pluripotent stem cells from ALS patients for disease modeling. Brain Research. 1607: 15-25. PMID 25223906 DOI: 10.1016/j.brainres.2014.09.017 |
0.321 |
|
| 2015 |
Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, ... ... Maragakis N, et al. ALSUntangled No. 29: MitoQ Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16: 427-429. DOI: 10.3109/21678421.2015.1050897 |
0.411 |
|
| 2015 |
Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, ... ... Maragakis N, et al. ALSUntangled: Introducing the table of evidence Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16: 142-145. DOI: 10.3109/21678421.2014.987476 |
0.428 |
|
| 2014 |
Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, Rothstein JD, Wang J. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 507: 195-200. PMID 24598541 DOI: 10.1038/Nature13124 |
0.448 |
|
| 2014 |
Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, ... ... Maragakis N, et al. ALSUntangled no. 26: Lunasin Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 622-626. DOI: 10.3109/21678421.2014.959297 |
0.4 |
|
| 2013 |
Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Heusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 80: 415-28. PMID 24139042 DOI: 10.1016/J.Neuron.2013.10.015 |
0.541 |
|
| 2013 |
Haidet-Phillips AM, Gross SK, Williams T, Tuteja A, Sherman A, Ko M, Jeong YH, Wong PC, Maragakis NJ. Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Experimental Neurology. 250: 250-9. PMID 24120466 DOI: 10.1016/J.Expneurol.2013.10.004 |
0.305 |
|
| 2013 |
Chad DA, Rowland LP, Armon C, Bedlack R, Durham H, Factor-Litvak P, Heiman-Patterson T, Heitzman D, Lacomis D, Ludolph A, Maragakis N, Miller R, Pattee G, Shoesmith C, Sorenson E, et al. Peer recommendations on how to improve clinical research, and Conference wrap-up. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 67-73. PMID 23678882 DOI: 10.3109/21678421.2013.778605 |
0.303 |
|
| 2013 |
Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 19-32. PMID 23678877 DOI: 10.3109/21678421.2013.778554 |
0.439 |
|
| 2013 |
Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, ... ... Maragakis N, et al. ALS Untangled No. 20: the Deanna protocol. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 319-23. PMID 23638638 DOI: 10.3109/21678421.2013.788405 |
0.498 |
|
| 2013 |
Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, et al. RNA Toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention [Neuron, 79, (September 18, 2013), 1222-1231] Neuron. 80: 1102. DOI: 10.1016/J.Neuron.2013.10.055 |
0.459 |
|
| 2012 |
Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Lládo J, Erkmen K, Redmond DE, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Science Translational Medicine. 4: 165ra164. PMID 23253611 DOI: 10.1126/Scitranslmed.3004579 |
0.536 |
|
| 2012 |
Wray S, Self M, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, ... ... Maragakis NJ, et al. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. Plos One. 7: e43099. PMID 22952635 DOI: 10.1371/Journal.Pone.0043099 |
0.447 |
|
| 2011 |
Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 108: 17803-8. PMID 21969586 DOI: 10.1073/Pnas.1103141108 |
0.306 |
|
| 2011 |
Lepore AC, Maragakis NJ. Stem cell transplantation for spinal cord neurodegeneration. Methods in Molecular Biology (Clifton, N.J.). 793: 479-93. PMID 21913120 DOI: 10.1007/978-1-61779-328-8_31 |
0.31 |
|
| 2011 |
Lepore AC, O'Donnell J, Bonner JF, Paul C, Miller ME, Rauck B, Kushner RA, Rothstein JD, Fischer I, Maragakis NJ. Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury. Journal of Neuroscience Research. 89: 1001-17. PMID 21488085 DOI: 10.1002/Jnr.22624 |
0.468 |
|
| 2011 |
Heiman-Patterson TD, Sher RB, Blankenhorn EA, Alexander G, Deitch JS, Kunst CB, Maragakis N, Cox G. Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 79-86. PMID 21241159 DOI: 10.3109/17482968.2010.550626 |
0.339 |
|
| 2011 |
Maragakis N, Rothstein JD. New treatments in amyotrophic lateral sclerosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 370-2. PMID 21116264 DOI: 10.1038/npp.2010.140 |
0.47 |
|
| 2010 |
Lepore AC, Tolmie C, O'Donnell J, Wright MC, Dejea C, Rauck B, Hoke A, Ignagni AR, Onders RP, Maragakis NJ. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiology of Disease. 39: 252-64. PMID 20381620 DOI: 10.1016/J.Nbd.2010.03.021 |
0.314 |
|
| 2010 |
Maragakis NJ. Motor neuron disease: progressive muscular atrophy in the ALS spectrum. Nature Reviews. Neurology. 6: 187-8. PMID 20379201 DOI: 10.1038/nrneurol.2010.29 |
0.337 |
|
| 2009 |
Papadeas ST, Maragakis NJ. Advances in stem cell research for Amyotrophic Lateral Sclerosis. Current Opinion in Biotechnology. 20: 545-51. PMID 19819686 DOI: 10.1016/j.copbio.2009.09.003 |
0.34 |
|
| 2008 |
Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nature Neuroscience. 11: 1294-301. PMID 18931666 DOI: 10.1038/Nn.2210 |
0.568 |
|
| 2008 |
Lepore AC, Dejea C, Carmen J, Rauck B, Kerr DA, Sofroniew MV, Maragakis NJ. Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Experimental Neurology. 211: 423-32. PMID 18410928 DOI: 10.1016/J.Expneurol.2008.02.020 |
0.348 |
|
| 2008 |
Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J, Price DL, Martin LJ, Wong PC. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 1997-2005. PMID 18305234 DOI: 10.1523/Jneurosci.4231-07.2008 |
0.544 |
|
| 2007 |
Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, Maragakis NJ, Rothstein JD. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Research. 1185: 256-65. PMID 17963733 DOI: 10.1016/J.Brainres.2007.09.034 |
0.505 |
|
| 2007 |
Maragakis NJ, Rothstein JD. Motor Neuron Disease: Amyotrophic Lateral Sclerosis Molecular Neurology. 307-319. DOI: 10.1016/B978-012369509-3.50022-6 |
0.524 |
|
| 2007 |
Maragakis NJ, Rothstein JD. Amyotrophic lateral sclerosis: Idiopathic and inherited Neurobiology of Disease. 521-535. DOI: 10.1016/B978-012088592-3/50048-7 |
0.549 |
|
| 2006 |
Maragakis NJ, Rothstein JD. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nature Clinical Practice. Neurology. 2: 679-89. PMID 17117171 DOI: 10.1038/ncpneuro0355 |
0.47 |
|
| 2006 |
Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I, Rubin LL, Drummond J, Krishnan C, Hoke A, Maragakis N, Shefner J, Rothstein JD, Kerr DA. Recovery from paralysis in adult rats using embryonic stem cells. Annals of Neurology. 60: 32-44. PMID 16802299 DOI: 10.1002/Ana.20901 |
0.473 |
|
| 2006 |
Pardo AC, Wong V, Benson LM, Dykes M, Tanaka K, Rothstein JD, Maragakis NJ. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Experimental Neurology. 201: 120-30. PMID 16753145 DOI: 10.1016/j.expneurol.2006.03.028 |
0.536 |
|
| 2006 |
Ganel R, Ho T, Maragakis NJ, Jackson M, Steiner JP, Rothstein JD. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiology of Disease. 21: 556-67. PMID 16274998 DOI: 10.1016/j.nbd.2005.08.014 |
0.508 |
|
| 2006 |
Lladó J, Haenggeli C, Pardo A, Wong V, Benson L, Coccia C, Rothstein JD, Shefner JM, Maragakis NJ. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiology of Disease. 21: 110-8. PMID 16084734 DOI: 10.1016/j.nbd.2005.06.019 |
0.517 |
|
| 2005 |
Maragakis NJ, Rao MS, Llado J, Wong V, Xue H, Pardo A, Herring J, Kerr D, Coccia C, Rothstein JD. Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitro. Glia. 50: 145-59. PMID 15657939 DOI: 10.1002/glia.20161 |
0.508 |
|
| 2004 |
Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Molecular and Cellular Neurosciences. 27: 322-31. PMID 15519246 DOI: 10.1016/j.mcn.2004.07.010 |
0.507 |
|
| 2004 |
Darman J, Backovic S, Dike S, Maragakis NJ, Krishnan C, Rothstein JD, Irani DN, Kerr DA. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 7566-75. PMID 15329404 DOI: 10.1523/JNEUROSCI.2002-04.2004 |
0.528 |
|
| 2004 |
Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiology of Disease. 15: 461-73. PMID 15056453 DOI: 10.1016/j.nbd.2003.12.007 |
0.461 |
|
| 2004 |
Maragakis NJ, Dykes-Hoberg M, Rothstein JD. Altered expression of the glutamate transporter EAAT2b in neurological disease. Annals of Neurology. 55: 469-77. PMID 15048885 DOI: 10.1002/ana.20003 |
0.504 |
|
| 2004 |
Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, Rao MS, Rothstein JD. Glutamate transporter expression and function in human glial progenitors. Glia. 45: 133-43. PMID 14730707 DOI: 10.1002/Glia.10310 |
0.473 |
|
| 2003 |
Kerr DA, Lladó J, Shamblott MJ, Maragakis NJ, Irani DN, Crawford TO, Krishnan C, Dike S, Gearhart JD, Rothstein JD. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5131-40. PMID 12832537 DOI: 10.1523/Jneurosci.23-12-05131.2003 |
0.51 |
|
| 2003 |
Maragakis NJ, Jackson M, Ganel R, Rothstein JD. Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice. Neuroscience Letters. 338: 107-10. PMID 12566164 DOI: 10.1016/S0304-3940(02)01386-1 |
0.554 |
|
| 2002 |
Patel SA, Maragakis NJ. Amyotrophic lateral sclerosis: pathogenesis, differential diagnoses, and potential interventions. The Journal of Spinal Cord Medicine. 25: 262-73. PMID 12482167 DOI: 10.1017/CBO9780511980053.013 |
0.309 |
|
| 2002 |
Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proceedings of the National Academy of Sciences of the United States of America. 99: 1604-9. PMID 11818550 DOI: 10.1073/pnas.032539299 |
0.555 |
|
| 2001 |
Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Archives of Neurology. 58: 365-70. PMID 11255439 DOI: 10.1001/Archneur.58.3.365 |
0.425 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. Plos One. 6: e25968. PMID 21998733 DOI: 10.1371/Journal.Pone.0025968 |
0.3 |
|
| 2012 |
Murinson BB, Haughey NJ, Maragakis NJ. Selected statins produce rapid spinal motor neuron loss in vitro. Bmc Musculoskeletal Disorders. 13: 100. PMID 22703530 DOI: 10.1186/1471-2474-13-100 |
0.293 |
|
| 2020 |
Wainger BJ, Macklin EA, Vucic S, McIlduff CE, Paganoni S, Maragakis NJ, Bedlack R, Goyal NA, Rutkove SB, Lange DJ, Rivner MH, Goutman SA, Ladha SS, Mauricio EA, Baloh RH, et al. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. Jama Neurology. PMID 33226425 DOI: 10.1001/jamaneurol.2020.4300 |
0.293 |
|
| 2017 |
Ilieva H, Maragakis NJ. Motoneuron Disease: Basic Science. Advances in Neurobiology. 15: 163-190. PMID 28674981 DOI: 10.1007/978-3-319-57193-5_6 |
0.292 |
|
| 2012 |
Rutkove S, Caress J, Cartwright M, Burns T, Warder J, David W, Goyal N, Maragakis N, Clawson L, Benatar M, Usher S, Sharma K, Gautam S, Narayanaswami P, Raynor E, et al. Electrical Impedance Myography as a Biomarker To Assess ALS Progression (S25.006) Neurology. 78: S25.006-S25.006. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S25.006 |
0.29 |
|
| 2012 |
Jablonski MR, Jacob DA, Campos C, Miller DS, Maragakis NJ, Pasinelli P, Trotti D. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. Neurobiology of Disease. 47: 194-200. PMID 22521463 DOI: 10.1016/J.Nbd.2012.03.040 |
0.29 |
|
| 2019 |
Taga A, Dastgheyb R, Habela C, Joseph J, Richard JP, Gross SK, Lauria G, Lee G, Haughey N, Maragakis NJ. Role of Human-Induced Pluripotent Stem Cell-Derived Spinal Cord Astrocytes in the Functional Maturation of Motor Neurons in a Multielectrode Array System. Stem Cells Translational Medicine. PMID 31631575 DOI: 10.1002/Sctm.19-0147 |
0.286 |
|
| 2009 |
Maragakis NJ. Rethinking a drug treatment failure on a traditional ALS target. Experimental Neurology. 216: 254-7. PMID 19309797 DOI: 10.1016/j.expneurol.2008.12.025 |
0.283 |
|
| 2019 |
Gross SK, Shim BS, Bartus RT, Deaver D, Mceachin Z, Betourne A, Boulis NM, Maragakis NJ. Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery. Experimental Neurology. 113091. PMID 31678350 DOI: 10.1016/J.Expneurol.2019.113091 |
0.28 |
|
| 2007 |
Lepore AC, Maragakis NJ. Targeted stem cell transplantation strategies in ALS. Neurochemistry International. 50: 966-75. PMID 17055612 DOI: 10.1016/J.Neuint.2006.09.005 |
0.28 |
|
| 2008 |
Magnus T, Carmen J, Deleon J, Xue H, Pardo AC, Lepore AC, Mattson MP, Rao MS, Maragakis NJ. Adult glial precursor proliferation in mutant SOD1G93A mice. Glia. 56: 200-8. PMID 18023016 DOI: 10.1002/Glia.20604 |
0.279 |
|
| 2021 |
Oskarsson B, Maragakis N, Bedlack RS, Goyal N, Meyer JA, Genge A, Bodkin C, Maiser S, Staff N, Zinman L, Olney N, Turnbull J, Brooks BR, Klonowski E, Makhay M, et al. MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design. Neurodegenerative Disease Management. PMID 34816762 DOI: 10.2217/nmt-2021-0042 |
0.276 |
|
| 2016 |
Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, Simmons Z, Maragakis NJ, McVey AL, Al-Lahham T, Heiman-Patterson TD, Andrews J, McDonnell E, Cudkowicz M, Atassi N. Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population. Journal of Clinical Neuromuscular Disease. 17: 99-105. PMID 26905909 DOI: 10.1097/Cnd.0000000000000102 |
0.262 |
|
| 2013 |
Chesi A, Staahl BT, JoviÄić A, Couthouis J, Fasolino M, Raphael AR, Yamazaki T, Elias L, Polak M, Kelly C, Williams KL, Fifita JA, Maragakis NJ, Nicholson GA, King OD, et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nature Neuroscience. 16: 851-5. PMID 23708140 DOI: 10.1038/Nn.3412 |
0.261 |
|
| 2016 |
Qosa H, Lichter J, Sarlo M, Markandaiah SS, McAvoy K, Richard JP, Jablonski MR, Maragakis NJ, Pasinelli P, Trotti D. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis. Glia. PMID 27158936 DOI: 10.1002/Glia.23003 |
0.26 |
|
| 2012 |
Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA, et al. Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 430-8. PMID 22591195 DOI: 10.3109/17482968.2012.684214 |
0.258 |
|
| 2007 |
Luo Y, Xue H, Pardo AC, Mattson MP, Rao MS, Maragakis NJ. Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1(G93A) mice. Journal of Neuroscience Research. 85: 2422-32. PMID 17567884 DOI: 10.1002/Jnr.21398 |
0.255 |
|
| 2017 |
Hoye ML, Koval ED, Wegener AJ, Hyman TS, Yang C, O'Brien DR, Miller RL, Cole T, Schoch KM, Shen T, Kunikata T, Richard JP, Gutmann DH, Maragakis NJ, Kordasiewicz HB, et al. microRNA profiling reveals marker of motor neuron disease in ALS models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28416596 DOI: 10.1523/Jneurosci.3582-16.2017 |
0.25 |
|
| 2015 |
Paganoni S, Hyman T, Shui A, Allred P, Harms M, Liu J, Maragakis N, Schoenfeld D, Yu H, Atassi N, Cudkowicz M, Miller TM. Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis. Muscle & Nerve. PMID 25900666 DOI: 10.1002/Mus.24688 |
0.25 |
|
| 2021 |
Lee H, Lee JJ, Park NY, Dubey SK, Kim T, Ruan K, Lim SB, Park SH, Ha S, Kovlyagina I, Kim KT, Kim S, Oh Y, Kim H, Kang SU, ... ... Maragakis NJ, et al. Publisher Correction: Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nature Neuroscience. PMID 34934204 DOI: 10.1038/s41593-021-01000-6 |
0.249 |
|
| 2017 |
Ilieva H, Maragakis NJ. Motoneuron Disease: Clinical. Advances in Neurobiology. 15: 191-210. PMID 28674982 DOI: 10.1007/978-3-319-57193-5_7 |
0.245 |
|
| 2015 |
Li K, Javed E, Scura D, Hala TJ, Seetharam S, Falnikar A, Richard JP, Chorath A, Maragakis NJ, Wright MC, Lepore AC. Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury. Experimental Neurology. PMID 26216662 DOI: 10.1016/J.Expneurol.2015.07.020 |
0.244 |
|
| 2019 |
van Vliet EA, Iyer AM, Mesarosova L, Çolakoglu H, Anink JJ, van Tellingen O, Maragakis NJ, Shefner J, Bunt T, Aronica E. Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients. Journal of Neuropathology and Experimental Neurology. PMID 31999342 DOI: 10.1093/jnen/nlz142 |
0.242 |
|
| 2023 |
Marshall KL, Rajbhandari L, Venkatesan A, Maragakis NJ, Farah MH. Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1 mutation. Scientific Reports. 13: 5597. PMID 37020097 DOI: 10.1038/s41598-023-31720-7 |
0.242 |
|
| 2006 |
Kim YS, Martinez T, Deshpande DM, Drummond J, Provost-Javier K, Williams A, McGurk J, Maragakis N, Song H, Ming GL, Kerr DA. Correction of humoral derangements from mutant superoxide dismutase 1 spinal cord. Annals of Neurology. 60: 716-28. PMID 17192933 DOI: 10.1002/Ana.21034 |
0.24 |
|
| 2011 |
Lepore AC, O'Donnell J, Kim AS, Yang EJ, Tuteja A, Haidet-Phillips A, O'Banion CP, Maragakis NJ. Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury. Glia. 59: 1996-2005. PMID 21882244 DOI: 10.1002/Glia.21241 |
0.238 |
|
| 2015 |
Li K, Javed E, Hala TJ, Sannie D, Regan KA, Maragakis NJ, Wright MC, Poulsen DJ, Lepore AC. Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 533-48. PMID 25492561 DOI: 10.1038/Mt.2014.236 |
0.238 |
|
| 2019 |
Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, Kisanuki YY, Zinman L, Jawdat O, Sorenson E, Floeter MK, Pioro EP, Fernandes Filho JAM, Heitzman D, Fournier CN, ... ... Maragakis N, et al. Primary Lateral Sclerosis (PLS) Functional Rating Scale: PLS-Specific Clinimetric Scale. Muscle & Nerve. PMID 31758557 DOI: 10.1002/Mus.26765 |
0.237 |
|
| 2010 |
Maragakis NJ. Stem cells and the ALS neurologist. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 417-23. PMID 20509745 DOI: 10.3109/17482968.2010.489116 |
0.237 |
|
| 2012 |
Shefner J, Barohn R, Boylan K, Bradshaw D, Brooks B, Heiman-Patterson T, Katz J, Maragakis N, Mitsumoto H, Pestronk A, Simmons Z, Wolff A, Lee J, Masonek J, Jones D, et al. A Study To Evaluate Safety, and Tolerability of Repeated Doses of CK-2017357 (CK-357) in Patients with Amyotrophic Lateral Sclerosis (S25.005) Neurology. 78: S25.005-S25.005. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S25.005 |
0.234 |
|
| 2014 |
Haidet-Phillips AM, Roybon L, Gross SK, Tuteja A, Donnelly CJ, Richard JP, Ko M, Sherman A, Eggan K, Henderson CE, Maragakis NJ. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Translational Medicine. 3: 575-85. PMID 24604284 DOI: 10.5966/Sctm.2013-0153 |
0.23 |
|
| 2018 |
Taga A, Maragakis NJ. Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics. 1-16. PMID 30273061 DOI: 10.1080/14737175.2018.1530987 |
0.229 |
|
| 2011 |
Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB. Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology. 77: 235-41. PMID 21676915 DOI: 10.1212/WNL.0b013e318225aabf |
0.229 |
|
| 2016 |
Srivastava AK, Gross SK, Almad AA, Bulte CA, Maragakis NJ, Bulte JW. Serial in vivoimaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology. PMID 28038988 DOI: 10.1016/j.expneurol.2016.12.011 |
0.223 |
|
| 2018 |
Almad A, Maragakis NJ. A stocked toolbox for understanding the role of astrocytes in disease. Nature Reviews. Neurology. PMID 29769699 DOI: 10.1038/s41582-018-0010-2 |
0.221 |
|
| 2017 |
Paganoni S, Bedlack R, Fixsen E, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, ... ... Maragakis N, et al. ALSUntangled No. 37: Inosine* Amyotrophic Lateral Sclerosis. 18: 309-312. PMID 27575981 DOI: 10.1080/21678421.2016.1223270 |
0.221 |
|
| 2016 |
Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27261500 DOI: 10.1136/Jnnp-2016-313521 |
0.218 |
|
| 2017 |
Maragakis NJ. What can we learn from the edaravone development program for ALS? Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 18: 98-103. PMID 28872911 DOI: 10.1080/21678421.2017.1361446 |
0.217 |
|
| 2020 |
Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, et al. Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS. The New England Journal of Medicine. 383: 109-119. PMID 32640130 DOI: 10.1056/Nejmoa2003715 |
0.217 |
|
| 2020 |
Goyal NA, Berry JD, Windebank A, Nathan P, Maragakis NJ, van den Berg LH, Genge A, Miller R, Baloh RH, Kern R, Gothelf Y, Lebovits C, Cudkowicz M. Addressing Heterogeneity in Als Clinical Trials. Muscle & Nerve. PMID 31899540 DOI: 10.1002/Mus.26801 |
0.212 |
|
| 2013 |
Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ, Tumani H, Ludolph AC, Meyer T, Calabresi PA, Paul F. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 1170-6. PMID 23582075 DOI: 10.1111/Ene.12146 |
0.209 |
|
| 2012 |
Almad AA, Maragakis NJ. Glia: an emerging target for neurological disease therapy. Stem Cell Research & Therapy. 3: 37. PMID 23021042 DOI: 10.1186/scrt128 |
0.206 |
|
| 2015 |
Grunseich C, Schindler AB, Chen KL, Bakar D, Mankodi A, Traslavina R, Ray-Chaudhury A, Lehky TJ, Baker EH, Maragakis NJ, Tifft CJ, Fischbeck KH. Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency. Journal of Neurology. 262: 1066-8. PMID 25736553 DOI: 10.1007/s00415-015-7683-x |
0.2 |
|
| 2023 |
Hatch J, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, Bowser R, Bromberg M, Brown A, Mascias Cadavid J, Carter GT, Cole N, Crayle J, Dimachkie M, Ennist D, ... ... Maragakis N, et al. ALSUntangled #70: caffeine. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-5. PMID 37288776 DOI: 10.1080/21678421.2023.2220742 |
0.195 |
|
| 2019 |
Richard JP, Hussain U, Gross S, Taga A, Kouser M, Almad A, Campanelli JT, Bulte JWM, Maragakis NJ. Perfluorocarbon Labeling of Human Glial-Restricted Progenitors for F Magnetic Resonance Imaging. Stem Cells Translational Medicine. PMID 30618148 DOI: 10.1002/sctm.18-0094 |
0.195 |
|
| 2014 |
Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Benatar M, Sharma KR, Narayanaswami P, Raynor EM, Watson ML, Shefner JM. Electrical impedance myography correlates with standard measures of ALS severity. Muscle & Nerve. 49: 441-3. PMID 24273034 DOI: 10.1002/mus.24128 |
0.193 |
|
| 2024 |
Salimpour Y, Anderson WS, Dastyeb R, Liu S, Ming GL, Song H, Maragakis NJ, Habela CW. Phase-Amplitude Coupling Detection and Analysis of Human 2-Dimensional Neural Cultures in Multi-well Microelectrode Array in Vitro. Journal of Neuroscience Methods. 110127. PMID 38615721 DOI: 10.1016/j.jneumeth.2024.110127 |
0.192 |
|
| 2024 |
Adashek JJ, Pandya C, Maragakis NJ, De P, Cohen PR, Kato S, Kurzrock R. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer. Bmc Medicine. 22: 74. PMID 38369520 DOI: 10.1186/s12916-024-03293-3 |
0.189 |
|
| 2008 |
Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Ståhlberg A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, ... ... Maragakis N, et al. Protective role of reactive astrocytes in brain ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 468-81. PMID 17726492 DOI: 10.1038/sj.jcbfm.9600546 |
0.189 |
|
| 2023 |
Shefner JM, Al-Chalabi A, Andrews JA, Chio A, De Carvalho M, Cockroft BM, Corcia P, Couratier P, Cudkowicz ME, Genge A, Hardiman O, Heiman-Patterson T, Henderson RD, Ingre C, Jackson CE, ... ... Maragakis NJ, et al. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-12. PMID 37254449 DOI: 10.1080/21678421.2023.2216223 |
0.186 |
|
| 2023 |
Maragakis NJ, de Carvalho M, Weiss MD. Therapeutic targeting of ALS pathways: Refocusing an incomplete picture. Annals of Clinical and Translational Neurology. PMID 37641443 DOI: 10.1002/acn3.51887 |
0.186 |
|
| 2003 |
Ueki T, Tanaka M, Yamashita K, Mikawa S, Qiu Z, Maragakis NJ, Hevner RF, Miura N, Sugimura H, Sato K. A novel secretory factor, Neurogenesin-1, provides neurogenic environmental cues for neural stem cells in the adult hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11732-40. PMID 14684875 DOI: 10.1523/Jneurosci.23-37-11732.2003 |
0.185 |
|
| 2009 |
Xue H, Wu S, Papadeas ST, Spusta S, Swistowska AM, MacArthur CC, Mattson MP, Maragakis NJ, Capecchi MR, Rao MS, Zeng X, Liu Y. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 1836-46. PMID 19544414 DOI: 10.1002/Stem.129 |
0.177 |
|
| 2018 |
Viguera C, Wang J, Mosmiller E, Cerezo A, Maragakis NJ. Olfactory dysfunction in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 5: 976-981. PMID 30128322 DOI: 10.1002/acn3.594 |
0.176 |
|
| 2023 |
Salimpour Y, Anderson WS, Dastyeb R, Liu S, Ming GL, Song H, Maragakis NJ, Habela CW. Phase-Amplitude Coupling Detection and Analysis of Human 2-Dimensional Neural Cultures in Multi-well Microelectrode Array in Vitro. Biorxiv : the Preprint Server For Biology. PMID 37502955 DOI: 10.1101/2023.07.08.548227 |
0.176 |
|
| 2008 |
Bedlack RS, Maragakis N, Heiman-Patterson T. Lithium may slow progression of amyotrophic lateral sclerosis, but further study is needed. Proceedings of the National Academy of Sciences of the United States of America. 105: E17; author reply E1. PMID 18417448 DOI: 10.1073/pnas.0801762105 |
0.175 |
|
| 2012 |
Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 439-45. PMID 22670883 DOI: 10.3109/17482968.2012.688837 |
0.173 |
|
| 2022 |
Mitsumoto H, Jang G, Lee I, Simmons Z, Sherman AV, Heitzman D, Sorenson E, Cheung K, Andrews J, Harms M, Shneider NA, Santella R, Paganoni S, Ajroud-Driss S, Fernandes JAM, ... ... Maragakis NJ, et al. Primary lateral sclerosis natural history study - planning, designing, and early enrollment. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-11. PMID 36576200 DOI: 10.1080/21678421.2022.2161912 |
0.173 |
|
| 2021 |
Ferraiuolo L, Maragakis NJ. Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets. Neuroscience Letters. 755: 135911. PMID 33892003 DOI: 10.1016/j.neulet.2021.135911 |
0.172 |
|
| 2017 |
Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM, Glass JD, Gross S, Mitsumoto H, Manfredi G. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Molecular Neurodegeneration. 12: 76. PMID 29065921 DOI: 10.1186/S13024-017-0217-5 |
0.163 |
|
| 2022 |
Sarmet M, Kabani A, Maragakis NJ, Mehta AK. Appetite and quality of life in amyotrophic lateral sclerosis: A scoping review. Muscle & Nerve. PMID 35986916 DOI: 10.1002/mus.27694 |
0.157 |
|
| 2000 |
Coffeen CM, McKenna CE, Koeppen AH, Plaster NM, Maragakis N, Mihalopoulos J, Schwankhaus JD, Flanigan KM, Gregg RG, Ptácek LJ, Fu YH. Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Human Molecular Genetics. 9: 787-93. PMID 10749986 DOI: 10.1093/Hmg/9.5.787 |
0.144 |
|
| 2023 |
Luo S, Angrick M, Coogan C, Candrea DN, Wyse-Sookoo K, Shah S, Rabbani Q, Milsap GW, Weiss AR, Anderson WS, Tippett DC, Maragakis NJ, Clawson LL, Vansteensel MJ, Wester BA, et al. Stable Decoding from a Speech BCI Enables Control for an Individual with ALS without Recalibration for 3 Months. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2304853. PMID 37875404 DOI: 10.1002/advs.202304853 |
0.142 |
|
| 2021 |
Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. Neurology. 20: 821-831. PMID 34536404 DOI: 10.1016/S1474-4422(21)00242-8 |
0.126 |
|
| 1992 |
Irwin RP, Maragakis NJ, Rogawski MA, Purdy RH, Farb DH, Paul SM. Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neuroscience Letters. 141: 30-4. PMID 1387199 DOI: 10.1016/0304-3940(92)90327-4 |
0.121 |
|
| 2023 |
Angrick M, Luo S, Rabbani Q, Candrea DN, Shah S, Milsap GW, Anderson WS, Gordon CR, Rosenblatt KR, Clawson L, Maragakis N, Tenore FV, Fifer MS, Hermansky H, Ramsey NF, et al. Online speech synthesis using a chronically implanted brain-computer interface in an individual with ALS. Medrxiv : the Preprint Server For Health Sciences. PMID 37425721 DOI: 10.1101/2023.06.30.23291352 |
0.114 |
|
| 2006 |
Maragakis NJ, Pardo AC. Amyotrophic lateral sclerosis presenting with a clivus mass and dysarthria Journal of Clinical Neuromuscular Disease. 8: 80-82. DOI: 10.1097/CND.0b013e31802b4c97 |
0.113 |
|
| 2016 |
Zigler JS, Hodgkinson CA, Wright M, Klise A, Sundin O, Broman KW, Hejtmancik F, Huang H, Patek B, Sergeev Y, Hose S, Brayton C, Xaiodong J, Vasquez D, Maragakis N, et al. A Spontaneous Missense Mutation in Branched Chain Keto Acid Dehydrogenase Kinase in the Rat Affects Both the Central and Peripheral Nervous Systems. Plos One. 11: e0160447. PMID 27472223 DOI: 10.1371/Journal.Pone.0160447 |
0.11 |
|
| 2020 |
Habela CW, Yoon KJ, Kim N, Taga A, Bell K, Bergles DE, Maragakis NJ, Ming GL, Song H. Persistent Cyfip1 expression is required to maintain the adult subventricular zone neurogenic niche. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31988061 DOI: 10.1523/Jneurosci.2249-19.2020 |
0.1 |
|
| 2017 |
Clawson LL, Cudkowicz M, Krivickas L, Brooks BR, Sanjak M, Allred P, Atassi N, Swartz A, Steinhorn G, Uchil A, Riley KM, Yu H, Schoenfeld DA, Maragakis NJ. A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 29191052 DOI: 10.1080/21678421.2017.1404108 |
0.097 |
|
| 2009 |
Lechtzin N, Maragakis NJ, Kimball R, Busse A, Hoffman V, Clawson L. Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 244-7. PMID 18985465 DOI: 10.1080/17482960802502993 |
0.089 |
|
| 2015 |
Maragakis NJ, Holland NR, Corse AM. Hemiparetic Primary Lateral Sclerosis: Revisiting Mills Syndrome. Case Reports in Neurology. 7: 191-5. PMID 26500542 DOI: 10.1159/000440713 |
0.083 |
|
| 2014 |
Mellos G, Bikos G, Maragakis N, Sioutis I, Roussos N, Patatoukas D. Influence of botulinum toxin in injection in gait velocity of patients with lower limb spasticity Annals of Physical and Rehabilitation Medicine. 57: e51. DOI: 10.1016/J.REHAB.2014.03.186 |
0.083 |
|
| 2023 |
Crone N, Candrea D, Shah S, Luo S, Angrick M, Rabbani Q, Coogan C, Milsap G, Nathan K, Wester B, Anderson W, Rosenblatt K, Clawson L, Maragakis N, Vansteensel M, et al. A click-based electrocorticographic brain-computer interface enables long-term high-performance switch-scan spelling. Research Square. PMID 37841873 DOI: 10.21203/rs.3.rs-3158792/v1 |
0.064 |
|
| 2012 |
Wadhwa V, Thakkar RS, Maragakis N, Höke A, Sumner CJ, Lloyd TE, Carrino JA, Belzberg AJ, Chhabra A. Sciatic nerve tumor and tumor-like lesions - uncommon pathologies. Skeletal Radiology. 41: 763-74. PMID 22410805 DOI: 10.1007/s00256-012-1384-7 |
0.043 |
|
| 2017 |
Beart P, Robinson M, Rattray M, Maragakis NJ. Erratum. Advances in Neurobiology. 15: E1. PMID 28905310 DOI: 10.1007/978-3-319-57193-5_21 |
0.031 |
|
| 2008 |
Murinson BB, Maragakis NJ, Jacobson TA. Fluvastatin, rhabdomyolysis, and myotoxicity. Mayo Clinic Proceedings. 83: 1296; author reply 1. PMID 18990330 DOI: 10.4065/83.11.1296 |
0.01 |
|
| Hide low-probability matches. |